(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease...
Stats | |
---|---|
本日の出来高 | 142.00 |
平均出来高 | 4 050.00 |
時価総額 | 5.60M |
EPS | $0 ( 2024-01-05 ) |
次の収益日 | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.840 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-31 | Abrams Michael S | Buy | 20 584 | Warrants (right to buy) |
2023-08-31 | Abrams Michael S | Buy | 10 292 | Common Stock |
2023-08-31 | Norchi Terrence W | Buy | 13 724 | Warrants (right to buy) |
2023-08-31 | Norchi Terrence W | Buy | 6 862 | Common Stock |
2023-08-31 | Hicks Laurence | Buy | 20 584 | Warrants (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 89 transactions |
Buy: 27 633 666 | Sell: 2 335 000 |
Arch Therapeutics, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Arch Therapeutics, Inc. 財務諸表
Annual | 2023 |
収益: | $75 724.00 |
総利益: | $-2 439.00 (-3.22 %) |
EPS: | $-2.27 |
FY | 2023 |
収益: | $75 724.00 |
総利益: | $-2 439.00 (-3.22 %) |
EPS: | $-2.27 |
FY | 2022 |
収益: | $15 652.00 |
総利益: | $-35 837.00 (-228.96 %) |
EPS: | $-3.56 |
FY | 2021 |
収益: | $11 565.00 |
総利益: | $-14 717.00 (-127.25 %) |
EPS: | $-0.0300 |
Financial Reports:
No articles found.
Arch Therapeutics, Inc.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。